| |
| |
|
| Insider
Information: |
Hamm Robert A |
| Relationship: |
Chief Operating Officer |
| City: |
Alpharetta |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,212 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,301,755 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,212 |
|
|
| Total
Value |
$6,301,755 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Chief Operating Officer |
2010-04-23 |
27,212 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business UnitO |
• – – |
2005-10-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,494 |
|
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2006-09-14 |
4 |
D |
$43.39 |
$359,833 |
D/D |
(8,293) |
25,701 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2006-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
24,500 |
33,994 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2006-09-19 |
4 |
AS |
$42.70 |
$693,307 |
D/D |
(16,207) |
9,494 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2007-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,467 |
14,961 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2007-02-06 |
4 |
D |
$48.94 |
$230,312 |
D/D |
(4,706) |
10,255 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2007-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
25,225 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2007-02-13 |
4 |
AS |
$49.22 |
$304,549 |
D/D |
(6,188) |
19,037 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2007-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
8,715 |
27,752 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2007-03-14 |
4 |
D |
$44.11 |
$160,472 |
D/D |
(3,638) |
24,114 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Immunology Business Unit |
• – – |
2007-03-20 |
4 |
AS |
$44.48 |
$225,819 |
D/D |
(5,077) |
19,037 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Neurology SBU |
• – – |
2007-04-23 |
4 |
AS |
$47.34 |
$176,633 |
D/D |
(3,731) |
15,306 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Neurology SBU |
• – – |
2007-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,700 |
30,006 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-06 |
4/A |
D |
$60.52 |
$108,210 |
D/D |
(1,788) |
33,685 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,467 |
35,473 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-06 |
4 |
D |
$60.52 |
$141,314 |
D/D |
(2,335) |
33,138 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-12 |
4 |
D |
$60.56 |
$96,109 |
D/D |
(1,587) |
32,098 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
14,040 |
42,459 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-12 |
4 |
AS |
$60.49 |
$224,100 |
D/D |
(3,679) |
28,419 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
14,040 |
46,138 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-12 |
4/A |
AS |
$60.49 |
$224,100 |
D/D |
(3,679) |
42,459 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-02-12 |
4/A |
D |
$60.56 |
$96,109 |
D/D |
(1,587) |
32,098 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-04-15 |
4 |
AS |
$63.48 |
$217,804 |
D/D |
(3,413) |
39,046 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-07-22 |
4 |
AS |
$70.00 |
$10,926,020 |
D/D |
(156,086) |
39,046 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Pharma. Oper. & Tech. |
• – – |
2008-07-22 |
4 |
OE |
$37.45 |
$8,158,826 |
D/D |
156,086 |
195,132 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
